ServiceUpdated on 14 August 2025
R&D of Generyc & Hybryd Drugs
About
From concept to market — we turn your ideas into successful products.
We offer a full-service approach to the development of generic and hybrid drugs, including:
-
Formulation development — over 40 ready-to-market formulations in our portfolio
-
Clinical trials — BA/BE/PK studies with in-house clinical and bioanalytical capabilities
-
Regulatory support — preparation and submission of documents to CTIS
-
Bioanalytical services — precise and fast LC-MS/MS analysis in compliance with EMA/FDA guidelines
Our expertise:
-
Cardiovascular and neurological drugs
-
Flexible service models: full-cycle development or standalone solutions tailored to your needs
With our experience and integrated facilities, we ensure speed, accuracy, and compliance — every step of the way.
Type
- Development
- Consulting
Applies to
- Pharmaceutical industry
- Laboratory industry
- Health innovation
Attached files
Organisation
Similar opportunities
Service
- Development
- Laboratory industry
- Pharmaceutical industry
Kseniya Tymko
Business Development Director at Pharmbiotest Poland Ltd
Grudziadz, Poland
Service
- Others
- Pharmaceutical industry
Kseniya Tymko
Business Development Director at Pharmbiotest Poland Ltd
Grudziadz, Poland